Assessment of age-related isoniazid hepatotoxicity during treatment of latent tuberculosis infection

Current Medical Research and Opinion

Volumn 22, Issue 1, 2006, Pages 217-221

  Aziz, Hany ^a,b   Shubair, Mohammed ^a,b   DeBari, Vincent A ^a,b   Ismail, Medhat ^a,b   Khan, M Anees ^a,b  

^a ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

^b SETON HALL UNIVERSITY   (United States)

Author keywords

Hepatotoxicity; Isoniazid; Liver function; Tuberculosis infection

Indexed keywords

ISONIAZID;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGE; AGING; ANOREXIA; CONFERENCE PAPER; DARK URINE; DISEASE PREDISPOSITION; DRUG EFFECT; DRUG USE; FATIGUE; FEMALE; HUMAN; JAUNDICE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; SYMPTOM; TUBERCULOSIS; UNITED STATES; URINE COLOR; VOMITING;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTITUBERCULAR AGENTS; FEMALE; HEPATITIS, TOXIC; HUMANS; ISONIAZID; LIVER; MALE; MIDDLE AGED; TUBERCULOSIS;

EID: 30844449442     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X80387     Document Type: Conference Paper

References (22)

1. Centers for Disease Control. Reported tuberculosis in the United States. US Department of Health and Human Services, Atlanta GA. September 2004
2. Centers for Disease Control. Prevention and control of tuberculosis in facilities providing long-term care to the elderly. MMWR Morb Mortal Wkly Rep 1990;39:7-20
3. Centers for Disease Control. A strategic plan for the elimination of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep 1989;38(Suppl S-3):1-25
4. American Thoracic Society. Preventive therapy of tuberculosis infection. Am Rev Respir Dis 1974;110:371-3
5. Taylor WC, Aronson MD, Delbanco TL. Should young adults with a positive tuberculin test take isoniazid? Ann Intern Med 1981;94:808-13
6. Mehta JB, Dutt AK, Harvill L, et al. Isoniazid preventive therapy for tuberculosis: are we losing our enthusiasm? Chest 1988;94:138-41
7. American Thoracic Society. Treatment of tuberculosis and other mycobacterial diseases. Am Rev Respir Dis 1983;127:790-6
8. Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: a seven year survey from a public health clinic. J Am Med Assoc 1999;281:1014-18
9. LoBue PA, Moser, KS. Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med 2003;168:443-7
10. American Thoracic Society. Targeted tuberculosis testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-47
11. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Adv Tuberc Res 1970;17:28-106
12. Efficacy of various durations of isoniazid preventative therapy for tuberculosis: five years of follow-up in the IUATL trial: International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ 1982;60:555-64
13. Whalen CC, Johnson JL, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immuno-deficiency virus. New Engl J Med 1997;337:801-8
14. Halsey NA, Coberty JC, Desormeaux J, et al. Randomized trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet 1998;351:786-92
15. Ferebee SH, Mount FW. Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. Am Rev Respir Dis 1962;85:490-521
16. Garibaldi RA, Drusin RE, Ferebee SH, Gregg MB. Isoniazid-associated hepatotoxicity: report of an outbreak. Am Rev Respir Dis 1972;106:357-65
17. Kopanoff DE, Snider DE, Caras GJ. Isoniazid-related hepatotoxicity: a US Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978;117:991-1001
18. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1359-74
19. Salpeter SR. Fatal isoniazid-induced hepatitis: its risk during chemoprophylaxis. West J Med 1993;159:560-4
20. Millard PS, Wiscosky TC, Reade-Christopher SJ, et al. Isoniazid-related fatal hepatitis. West J Med 1996;164:486-91
21. Steele MA, Burk RF, DesPrez RM. Toxic hepatotoxicity with isoniazid and rifampin: a meta-analysis. Chest 1991;99:465-71
22. Fountain FF, Tolley E, Chrisman CR, et al. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection. Chest 2005;128:116-23